期刊文献+

我院2014年1~6月门诊降血脂药应用分析

下载PDF
导出
摘要 对我院门诊2014年1~6月降血脂药物的消耗金额、用药频度( DDDs)及构成比、日均用药费用( DDC)等进行统计分析。本院所用各类降血脂药物中他汀类药物的总金额和DDDs所占比重最大,其中阿托伐他汀片占主导地位,多廿烷醇的DDC最高。
作者 王飞羽
出处 《海峡药学》 2015年第2期209-210,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献4

二级参考文献15

  • 1Qing He Nie Yong Qian Cheng Yu Mei Xie Yong Xing Zhou Yi Zhan Cao The Center of Infectious Disease Diagnosis and Treatment of PLA,Tangdu Hospital,Forth Military Medical University,Xi’an 710038,Shaanxi Province,ChinaDr,Qing He Nie graduated from Qinghai Medical College as a doctor in 1983,got master degree at Beijing 302 Army Hospital in 1993,got doctor degree at the Third Military Medical University in 1998,engaged in postdoctoral research at the Fourth Military Medical University from 1998 to 2000,now an associate professor,specialized in clinical and experimental research of infectious diseases,had more than 90 papers published,coauthor of ten books,first author of one book..Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis[J].World Journal of Gastroenterology,2001,7(3):363-369. 被引量:73
  • 2张冬颖,覃数.他汀类药物改善心室重塑的研究进展[J].重庆医学,2004,33(10):1581-1583. 被引量:17
  • 3杜建层,周秀芹,庞义存,郭影.辛伐他汀对去卵巢大鼠血清IL-6、IGF-Ⅰ及成骨细胞BMP-2表达的影响[J].中国老年学杂志,2005,25(4):442-444. 被引量:10
  • 4王志华,张国元,王华梁.阿西莫司、普鲁布可、川芎嗪对兔主动脉粥样硬化的影响[J].第二军医大学学报,1995,16(5):417-419. 被引量:9
  • 5Assman G, chuhe H, Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middleaged men [J]. Am J Cardiol, 1996, 77: 1179-1184.
  • 6Austin MA. Epidemiology of hypertriglyceridemia and cardio - vascular disease [J]. Am J Cardiol, 1999, 83: 13.
  • 7Shepherd J, Kauss RM. Pathophysiology of triglyceride - rich particles [J]. Am J Cardiol, 1991, 68: 5.
  • 8Alcocer L, Fernandezl, Campose, et al. A comparative study of policosanol Versus acipimox in patients with type Ⅱ hypercholesterolemia[J]. Int J Tissue React, 1999, 21 : 85 -92.
  • 9Stuytpm, Kleinjans HA, Stalenhoef AF. Tolerability and effects of high doses acipimox as additional lipid - lowering therapy in familial hypercholesterolemia [J]. Neth J Med, 1998, 53:228-233.
  • 10Ko GT, Mark TW, Yeung VT, et al. Short- term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia [ J ], J Clin Pharmacol, 1998, 38: 912-917.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部